GLP1R agonist mAbs (Innovative Targeting Solutions)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGLP1R agonist mAbs (Innovative Targeting Solutions)
Drug Alias Nameanti-GLP1R peptide grafted mAbs (Innovative Targeting Solutions)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovative Targeting Solutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovative Targeting Solutions Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A